Updates

Get Alerts
September 27, 2023 | PPP Updates
Spesolimab-sbzo for the management of generalized pustular psoriasis flares
Jenna Mills, PharmD, BCPS, Assistant Professor of Pharmacy Practice, Suzanne Surowiec, PharmD, BCACP, Associate Professor of Teaching in Pharmacy Practice, Celeste VanAtta, PharmD, BCPS, Assistant Professor of Pharmacy Practice
September 27, 2023 | PPP Updates
New data evaluating the role of aspirin for the prevention of venous thromboembolism
Megan C. Herink, PharmD, MBA, BCPS, Clinical Associate Professor
August 21, 2023 | PPP Updates
Ending the HIV epidemic through preventative measures
Daniel Rogers, PharmD, Daniel B. Chastain, PharmD, BCIDP, AAHIVP
August 16, 2023 | PPP Updates
Surviving Sepsis and Antimicrobial Stewardship in the Emergency Department
Kelly Betts, PharmD, Carolina Woloszyn, PharmD, Madeline Belk, PharmD
August 1, 2023 | PPP Updates
New Fecal Microbiota Products for the Prevention of Recurrent Clostridioides difficile Infection
Victoria Madonia, Johny Nguyen, P. Brandon Bookstaver, PharmD, BCIDP, FCCP, FIDSA
August 1, 2023 | PPP Updates
Donepezil Transdermal System (Adlarity®): The First Once-Weekly Patch Approved for Treatment of Mild, Moderate, and Severe Alzheimer’s Dementia
Mary Ngo, PharmD
July 26, 2023 | PPP Updates
2023 Update to the AGS Beers Criteria®
Jeannie K. Lee, PharmD, BCPS, BCGP, FASHP, AGSF, Associate Professor of Department of Pharmacy Practice & Science and Assistant Dean for Student Services
July 21, 2023 | PPP Updates
Tirzepatide: a first-in-class medication to lower blood sugar and treat type 2 diabetes mellitus
Adriane N Irwin, MS, PharmD, BCACP, CDCES, Katie Windsor, PharmD
July 7, 2023 | PPP Updates
Drug shortages and alternative therapy considerations in the critical care population
Kimberly Terry, PharmD, MS, BCCCP, BCPS, Laura Steffens, PharmD, MS, BCCCP
July 7, 2023 | PPP Updates
Lenacapavir for Treatment of Multidrug-resistant HIV-1 Infection
Sarah Al Mansi, MD, Janice Heintze, MD, Kamla Sanasi-Bhola, MD, P. Brandon Bookstaver, PharmD, FCCP, FIDSA, BCIDP
April 19, 2023 | PPP Updates
Elacestrant Approved for ER-Positive, HER2-Negative, ESR1 Mutated Breast Cancer
Jill M. Kolesar, PharmD, MS
April 18, 2023 | PPP Updates
Guideline update for the treatment of children and adolescents with major and persistent depressive disorders
Tiffany H. Tran, PharmD, BCPP, Assistant Professor
March 15, 2023 | PPP Updates
Novel Drugs Approved for Psoriasis in 2022
Matthew Sherman, PharmD, MBA, Austin Mondloch, PharmD, MA, Genevieve Lynn Ness, PharmD
March 15, 2023 | PPP Updates
Inpatient Management of COVID-19
Shreena Advani, PharmD, BCIDP, Manish Patel, PharmD, BCPS, BCIDP, Joseph Torrisi, PharmD, BCIDP
March 9, 2023 | PPP Updates
Maribavir: A New Treatment For Resistant Cytomegalovirus Infections
Sahand Golpayegany, PharmD, Megan C. Kelly, PharmD, MPH, Sarah B. Green, PharmD, BCIDP, AAHIVP
February 22, 2023 | PPP Updates
Clinical Updates for Managing Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Adults
Daniel T. Anderson, PharmD, BCIDP, Antimicrobial Stewardship Pharmacist, Joshua Eudy, PharmD, BCIDP, Antimicrobial Stewardship Pharmacist
January 10, 2023 | PPP Updates
Dabrafenib in Combination with Trametinib Approved for Unresectable or Metastatic Tumors with BRAF V600E Mutation
Lauren Dietz, PharmD candidate, Jill M. Kolesar, PharmD, MS
January 10, 2023 | PPP Updates
Tralokinumab for the Management of Moderate-to-Severe Atopic Dermatitis
Celeste (Voight) VanAtta, PharmD, BCPS, Jenna Mills, PharmD, BCPS, Suzanne Surowiec, PharmD, BCACP
January 9, 2023 | PPP Updates
Short-course rifapentine-based regimen for the treatment of drug-susceptible pulmonary tuberculosis
Rachel Musgrove, PharmD, BCIDP
January 9, 2023 | PPP Updates
Updates in the Management of AmpC-producing Enterobacterales
Laysa Vasquez, PharmD, BCPS, Clinical Pharmacist, Megan Seddon, PharmD, BCIDP, Antimicrobial Stewardship Pharmacist
December 6, 2022 | PPP Updates
Inclisiran: A Newly Approved Cholesterol Lowering Medication
Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, Clinical Associate Professor
December 5, 2022 | PPP Updates
Management of Gram-Negative Bacteremia: Focus on the duration of treatment
Julia Kim, PharmD, Patrick Tu, PharmD, BCPS, AAHIVP
November 21, 2022 | PPP Updates
Daridorexant (Quviviq®): A Dual Orexin Receptor Antagonist for Adults with Insomnia
Jamie Kneebusch, PharmD, BCPS, BCPP
November 21, 2022 | PPP Updates
Futibatinib Approved for Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma
Lauren Dietz, PharmD candidate, Jill M. Kolesar, PharmD, MS
September 30, 2022 | PPP Updates
Approval of the Combination Nirmatrelvir/Ritonavir (Paxlovid™) for the Treatment of COVID-19 in the Outpatient Setting
Linda C Klumpp, MD1, Natalie Harris, PharmD Candidate 20232, Delvin Omer, PharmD Candidate 20232, P. Brandon Bookstaver, PharmD2